Literature DB >> 35976487

Cell Death Mechanisms in Cerebral Ischemia-Reperfusion Injury.

Qian Zhang1,2,3,4, Meng Jia2,3,4, YunFu Wang5, Qun Wang2,4, Jianping Wu6,7,8,9.   

Abstract

Ischemic stroke is one of the major causes of morbidity and mortality, affecting millions of people worldwide. Inevitably, the interruption of cerebral blood supply after ischemia may promote a cascade of pathophysiological processes. Moreover, the subsequent restoration of blood flow and reoxygenation may further aggravate brain tissue injury. Although recombinant tissue plasminogen activator (rt-PA) is the only approved therapy for restoring blood perfusion, the reperfusion injury and the narrow therapeutic time window restrict its application for most stroke patients. Increasing evidence indicates that multiple cell death mechanisms are relevant to cerebral ischemia-reperfusion injury, including apoptosis, necrosis, necroptosis, autophagy, pyroptosis, ferroptosis, and so on. Therefore, it is crucial to comprehend various cell death mechanisms and their interactions. In this review, we summarize the various signaling pathways underlying cerebral ischemia-reperfusion injury and elaborate on the crosstalk between the different mechanisms.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Apoptosis; Autophagy; Cerebral ischemia–reperfusion; Necroptosis; Necrosis

Year:  2022        PMID: 35976487     DOI: 10.1007/s11064-022-03697-8

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   4.414


  139 in total

Review 1.  Cell Death Signaling.

Authors:  Douglas R Green; Fabien Llambi
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-12-01       Impact factor: 10.005

Review 2.  Apoptosis: a review of programmed cell death.

Authors:  Susan Elmore
Journal:  Toxicol Pathol       Date:  2007-06       Impact factor: 1.902

Review 3.  Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy.

Authors:  Peter E Czabotar; Guillaume Lessene; Andreas Strasser; Jerry M Adams
Journal:  Nat Rev Mol Cell Biol       Date:  2014-01       Impact factor: 94.444

Review 4.  The rheostat in the membrane: BCL-2 family proteins and apoptosis.

Authors:  N Volkmann; F M Marassi; D D Newmeyer; D Hanein
Journal:  Cell Death Differ       Date:  2013-10-25       Impact factor: 15.828

Review 5.  Cell biology of ischemia/reperfusion injury.

Authors:  Theodore Kalogeris; Christopher P Baines; Maike Krenz; Ronald J Korthuis
Journal:  Int Rev Cell Mol Biol       Date:  2012       Impact factor: 6.813

Review 6.  Apoptosis in the nervous system.

Authors:  J Yuan; B A Yankner
Journal:  Nature       Date:  2000-10-12       Impact factor: 49.962

7.  miR-21 represses FasL in microglia and protects against microglia-mediated neuronal cell death following hypoxia/ischemia.

Authors:  Li Zhang; Lian-Yan Dong; Ya-Jian Li; Zhen Hong; Wen-Shi Wei
Journal:  Glia       Date:  2012-08-20       Impact factor: 7.452

8.  Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association.

Authors:  Gregory J Del Zoppo; Jeffrey L Saver; Edward C Jauch; Harold P Adams
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

Review 9.  Cell Death Pathways in Ischemic Stroke and Targeted Pharmacotherapy.

Authors:  Aishika Datta; Deepaneeta Sarmah; Leela Mounica; Harpreet Kaur; Radhika Kesharwani; Geetesh Verma; Pabbala Veeresh; Vignesh Kotian; Kiran Kalia; Anupom Borah; Xin Wang; Kunjan R Dave; Dileep R Yavagal; Pallab Bhattacharya
Journal:  Transl Stroke Res       Date:  2020-03-26       Impact factor: 6.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.